article · The Lancet Infectious Diseases

Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial

Videlis Nduba
Ole F. Olesen
Maphoshane Nchabeleng
Stefan H. E. Kaufmann
Marit Holleman
Andrea Gutschmidt
Leander Grode
Linda Rosset Buluma
Megan Dempster
Nelson Twinamasiko
Marcus May
Rafiou Adamou
Aditi Bhargava
Renate Strehlau
Dhananjay Kapse
Victoria Nankabirwa
Issa Sabi
Anne Wajja
Carlos Lamsfus Calle
Rolf Fendel
Vidya Niranjan
Mercy Mwale
Ayôla Akim Adégnika
Jacqueline Mirera
Beno Huglin
Dineo Noko
Ingrid Ramboho
Shaun Barnabas
Jerry Hella
Prasad S. Kulkarni
Umesh Shaligram
Tresphory Zumba
Francis Mhimbira
Diane Egger-Adam
Alison Elliott
Mark F Cotton
Jana Meiring
Lauren Davidow
Victoria Namazzi
Anange L willa
Reinfrida Ngailo
Els Dobbles
January Weiner
Stefan H E Kaufmann
Rick Elsy Mirna N'noh Dansou Akoua
Agatha Ronah Namuwonge
Mark.F Cotton
Kim Robertson
Bayodé Roméo Adégbitè
Sajjad Desai

2026University of the Western Cape

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/s1473-3099(26)00374-9

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.

Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial

In plain language

Research topics

Sustainable Development Goals

Read the original research

Discuss this research